Slow or troubled healing processes are one of the many negative outcomes of diabetes and many other human diseases.
Diabetes patients not only show deficient tissue healing of sharp wounds but they are also more prone to suffer from chronic wounds, such as ulcers in the lower limbs.
Looking for ways to improve the healing process in diabetes patients, the research group for the Traslacional Investigation of Biomaterials and Tissue Engineering of the “Universidad de Alcalá” managed by Doctor Juan Manuel Bellón and Doctor Julia Buján and working in collaboration with the CSIC have developed an experimental model that releases growth hormone (GH) in a gradual and controlled manner directly over the wounded area. This improves the healing process, with the added advantage that the localised application method avoids the negative side effects that a systemic administration of the hormone could raise.